A common microvascular complication of type 1 diabetes.

The DCCT/EDIC Research Group: Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes Retinopathy, a common microvascular complication of type 1 diabetes, is a leading cause of vision loss worldwide.1 In the Diabetes Control and Complications Trial ,2 6.5 years of intensive therapy aimed at achieving glycemia as close to the nondiabetic range as safely possible, in comparison with conventional therapy at that time, was associated with a 76 percent reduction in the onset of retinopathy and a 52 percent reduction in disease progression over the counter ed treatment .

At the final end of 2014, BioMed Central and other publishers alerted the international Committee on Publication Ethics to new forms of systematic attempts to manipulate journals’ peer-review processes. According to a declaration published on COPE’s site in January 2015, these attempts to hijack the scholarly review system were apparently orchestrated by firms that 1st helped authors write or enhance their scientific articles and sold them favorable peer testimonials.4 BioMed Central conducted a comprehensive investigation of most their recently published articles and identified 43 which were published based on reviews from fabricated reviewers.